X

Orchid Pharma Limited Q4FY23 Earnings Story

Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Financial Results:

  • Orchid Pharma Ltd. reported Total Income for Q4FY23 of ₹ 212 Crores up from ₹ 180 Crore year on year, a rise of 18%.

  • Total Expenses for Q4FY23 of ₹ 185 Crores up from ₹ 183 Crores year on year, rise of 1%.

  • Consolidated Net Profit of ₹ 59 Crores, up from a loss of ₹ 7 Crores in the same quarter of the previous year.

  • The Earnings per Share is ₹ 14.49, up from ₹ -1.61 in the same quarter of the previous year.
Related Post